Banque de Luxembourg Investments (BLI)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Hold
136,500
0.35% 72
2025
Q4
$12M Sell
136,500
-63,900
-32% -$4.85M 0.35% 74
2025
Q3
$11.3M Buy
200,400
+61,600
+44% +$3.55M 0.33% 86
2025
Q2
$8.13M Buy
138,800
+15,800
+13% +$1.02M 0.23% 103
2025
Q1
$8.91M Sell
123,000
-32,000
-21% -$2.64M 0.27% 94
2024
Q4
$12.8M Buy
+155,000
New +$12.2M 0.35% 80

Other funds holding GMED

Banque de Luxembourg Investments (BLI)'s GMED Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its Globus Medical (GMED) position steady in Q1 2026 at 136,500 shares worth $11.8M. The position accounts for 0.35% of the portfolio, ranked #72.

Banque de Luxembourg Investments (BLI) first reported a position in GMED in Q4 2024 and has held it in 6 quarters since. The position peaked at $12.8M in Q4 2024. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 136,500 shares of Globus Medical worth $11.8M as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its Globus Medical share count unchanged in Q1 2026.
  • Globus Medical made up 0.35% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #72 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Globus Medical in Q4 2024 and has held it in 6 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Globus Medical position peaked at $12.8M in Q4 2024.
  • 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.